BridgeBio Pharma (BBIO) Accounts Payables (2018 - 2026)
BridgeBio Pharma's Accounts Payables came in at $27.2 million for Q2 2026, up 4.1% from $26.13 million a year earlier but down 6.4% from the prior quarter.
BridgeBio Pharma (BBIO) Accounts Payables (2018 - 2026) Analysis & Trends
At the end of FY2025, BridgeBio Pharma's Accounts Payables was $36.23 million, up 276.7% from FY2024.
- Accounts Payables carries a five-year compound annual growth rate of 32.3% (FY2020 to FY2025).
- Going back by year, Accounts Payables was $9.62 million in FY2024 (-9.7%), $10.66 million in FY2023 (-7.8%), $11.56 million in FY2022 (-2.7%) and $11.88 million in FY2021 (+32.9%).
- The five-year range for quarterly Accounts Payables is $3.87 million (Q2 2023) to $36.23 million (Q4 2025).
- Year-over-year, Accounts Payables has increased for six consecutive quarters, with growth averaging 130.2% over the last eight quarters.
- The fastest year-over-year change in Accounts Payables over five years came in Q1 2025 (growth of 482.2%), and the weakest in Q2 2022 (a decline of 60.6%).
- Business Quant data shows BBIO's Accounts Payables at $29.06 million (Q1 2026), $36.23 million (Q4 2025) and $18.7 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 4.58 Bn |
| 10 | BridgeBio Pharma | 13.39 Bn | 10.50 Bn | 228.63 Mn | 27.20 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.20 Mn |
| Mar 31, 2026 | 29.06 Mn |
| Dec 31, 2025 | 36.23 Mn |
| Sep 30, 2025 | 18.70 Mn |
| Jun 30, 2025 | 26.13 Mn |
| Mar 31, 2025 | 27.53 Mn |
| Dec 31, 2024 | 9.62 Mn |
| Sep 30, 2024 | 13.36 Mn |
| Jun 30, 2024 | 18.13 Mn |
| Mar 31, 2024 | 4.73 Mn |
| Dec 31, 2023 | 10.66 Mn |
| Sep 30, 2023 | 4.47 Mn |
| Jun 30, 2023 | 3.87 Mn |
| Mar 31, 2023 | 4.08 Mn |
| Dec 31, 2022 | 11.56 Mn |
| Sep 30, 2022 | 10.16 Mn |
| Jun 30, 2022 | 8.79 Mn |
| Mar 31, 2022 | 10.11 Mn |
| Dec 31, 2021 | 11.88 Mn |
| Sep 30, 2021 | 12.04 Mn |
BridgeBio Pharma Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=BBIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();